Anticoagulant
Low-Intensity Apixaban for Blood Clots
Recruiting2 awardsPhase 4
Boston, Massachusetts
This trial is testing low-intensity apixaban versus placebo for extended prevention of recurrence after provoked VTE in patients with at least one persistent provoking factor. The primary safety outcome is ISTH major bleeding at 12 months, and the primary efficacy outcome is symptomatic, recurrent VTE at 12 months.
Anticoagulant
Apixaban vs Enoxaparin for Bladder Cancer
Recruiting1 award
Philadelphia, Pennsylvania
"This trial aims to compare the experiences of bladder cancer patients taking blood thinners at home after bladder surgery. It wants to know if patients are equally good at following the instructions for apixaban and en
Device
ClotTriever vs Anticoagulation for Deep Vein Thrombosis
Recruiting1 award5 criteria
Denver, Colorado
This trial compares the effectiveness of the ClotTriever System, which removes blood clots from veins, to standard blood-thinning medication in patients with symptomatic blood clots in one leg. The ClotTriever System, developed by Inari Medical, is a mechanical device used to treat deep vein thrombosis (DVT) by removing blood clots from veins.
Anticoagulant
Non-vitamin K oral anticoagulants (NOACs) +1 More for Atrial Fibrillation
Recruiting3 awardsPhase 2
Vancouver, British Columbia
This trial will conduct a small study to compare different blood thinners in people at risk for blood clots after open-heart surgery. The aim is to gather data to design a larger study to test the
Popular Filters
Phase 3 Trials
Anticoagulant
Apixaban vs Aspirin for Stroke Prevention in Atrial Fibrillation After Brain Bleed
Recruiting1 awardPhase 3
Birmingham, Alabama
This trial is testing whether apixaban is better than aspirin at preventing strokes or death in patients who have recently had a bleed in the brain and also have atrial fibrillation.
Factor Xa Inhibitor
Milvexian vs Apixaban for Atrial Fibrillation
Recruiting1 awardPhase 3
Alexander City, Alabama
This trial is testing a new medication called milvexian to see if it can prevent strokes and blood clots as well as an existing drug, apixaban. Apixaban (Eliquisâ„¢) was developed by Bristol-Myers Squibb and Pfizer and has been approved for the prevention of stroke in patients with certain heart conditions. The study focuses on patients who are at risk of these serious conditions. Milvexian works by helping to keep the blood flowing smoothly, reducing the chances of dangerous clots forming.
Monoclonal Antibodies
Abelacimab vs Apixaban for Cancer-Related Blood Clots
Recruiting2 awardsPhase 3
Detroit, Michigan
This trial is testing abelacimab, a medication, to prevent blood clots in cancer patients who have had previous clots. It aims to see if it works better and causes fewer bleeding problems compared to a current treatment.
Anticoagulant
Timing of Anticoagulation After Intracranial Hemorrhage
Recruiting2 awardsPhase 3
Austin, Texas
This trial is testing whether it is better to restart oral anticoagulation a week after a traumatic brain bleed, or 2 or 4 weeks later. The primary outcome is a composite of thromboembolic events (DVT, pulmonary emboli, etc) and bleeding events.
Trials With No Placebo
Anticoagulant
Blood Thinners for Atrial Fibrillation
Recruiting3 awardsPhase 4
Edmonton, Alberta
This trial is testing whether taking blood-thinning pills can prevent strokes and other heart issues in patients who have temporary irregular heartbeats and are at risk of stroke after surgery. These pills are a recent breakthrough in preventing strokes.
Anticoagulant
Anticoagulants vs Antiplatelets for Blood Clot Prevention After Heart Procedure
Recruiting3 awardsPhase 4
Quebec
This trial compares two ways to prevent blood clots around a device used to treat heart problems. One is a short course of a blood thinner called a DOAC. The other is a daily antiplatelet pill.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.